Combined & Adaptive FIH Trials

Why choose combined and adaptive clinical trials from SGS?

We offer a comprehensive range of consultancy services to support the development and execution of complex and adaptive early phase clinical trials. In recent years, 75% of FIH trials at our clinical pharmacology unit (CPU) incorporate complex design protocols, with nearly 50% containing adaptive features. Most FIH studies also contain pharmacodynamic read outs to enable pharmacology assessment and/or POC.

Our expert teams design the combined approach, ensuring compliance with regulatory requirements and ethics committees. They will help define the study’s progression rules and safety boundaries, a vital component of any trial design process.

SGS is recognized as the benchmark for quality and integrity in clinical trials. Our solutions ensure you can optimize relevant data collection while ensuring safety and reducing the time spent conducting the trial.